Related by context. All words. (Click for frequent words.) 73 Levulan ® photodynamic therapy 70 Levulan ® Photodynamic Therapy 66 aminolevulinic acid ALA 65 verteporfin 61 Kerastick ® revenues 60 Metvixia 59 photosensitizing agent 58 Inhalation Solution 58 KSP inhibitor 58 Squalamine 57 immunoconjugate 57 PORxin TM 57 HDAC Inhibitor 56 topically administered 56 abacavir Ziagen 56 directed thrombolysis 56 Adefovir 56 novel peptide 56 Pimavanserin 56 aminolevulinic acid 56 Factor VIIa 56 pan HDAC inhibitor 55 nucleoside analog 55 Reports Preclinical Data 55 Kinase Inhibitor 55 Pliable Display Technology 55 Alfacell proprietary ribonuclease 55 antimitotic 55 Guanilib 55 Antiviral Therapy 55 nucleoside analogues 55 MGd 55 systemic RNAi therapeutic 55 GW# [003] 55 Janus Kinase 55 targeted antifolate 55 Percutaneous Tibial Nerve Stimulation 55 metastatic neuroendocrine tumors 55 Liposomal 54 inhibitor RG# 54 Novel Oral 54 Photodynamic Therapy 54 protein kinase inhibitors 54 small molecule tyrosine 54 Present Preclinical Data 54 antisense inhibitor 54 FVIIa 54 selective antagonist 54 histone deacetylase HDAC inhibitor 54 dexpramipexole 54 SYN# 54 Decitabine 54 Presents Preclinical Data 54 ALK inhibitor 54 abstr 54 Glypromate 54 vitamin D analogs 54 Tyrosine Kinase Inhibitors 54 liposome formulation 53 paclitaxel Taxol 53 AKT inhibitor 53 prolyl hydroxylase inhibitors 53 Cytotoxic 53 lexidronam injection 53 Fulvestrant 53 TLR9 agonist 53 p# inhibitor 53 busulfan 53 Symadex 53 Elan NanoCrystal 53 Parathyroid Hormone 53 Preclinical Data 53 agonist compounds 53 Aurora Kinase 53 reporter Tim Warsinskey 53 liposomal formulation 53 Locked Nucleic Acid 53 Bosutinib 53 humanized monoclonal 52 Abstract Number 52 TÎ ² 4 52 rxRNA 52 Blinatumomab 52 Pathway Inhibitor 52 NanoEmulsion 52 Oral Session 52 RezularTM 52 proteasome inhibitor 52 irreversible inhibitor 52 nucleotide analog 52 oral JAK1 52 By AARON TURNER 52 Talabostat 52 Safinamide 52 NNR Therapeutics 52 Tesetaxel 52 small molecule activators 52 EGFR HER2 52 Parkinson Foundation PFNCA 52 fosbretabulin 52 By Shoshana Walter 52 Locked Nucleic Acid LNA 52 Tyrosine Kinase Inhibitor 52 selective kinase inhibitor 52 CCX# 52 NMDA antagonists 52 cidofovir 52 Phase Ib Clinical Trial 52 idiopathic thrombocytopenic purpura 52 Immunotherapeutic 52 Interferon alfa 51 subcutaneous immunoglobulin 51 antiepileptics 51 See CLINICAL PHARMACOLOGY 51 RNA antagonist 51 small molecule agonists 51 nicotinic acetylcholine receptor 51 beta 1a 51 drug zotarolimus 51 multidrug therapy 51 VentiRx Pharmaceuticals 51 DUROS 51 molecular biomarkers 51 Anti Tumor 51 Antiviral Activity 51 Degarelix 51 JAK2 inhibitor 51 Oral Presentation 51 Diabetic Neuropathy 51 microtubule inhibitor 51 OHR/AVR# 51 Temsirolimus 51 Receptor Antagonists 51 generation antisense 51 Camptothecin 51 Bremelanotide 51 antiangiogenic agent 51 teriflunomide 51 Tigecycline 51 small molecule activator 51 Placebo Controlled Study 51 Ricardo Bilton 51 CEQ# 51 tacrolimus ointment 51 Interferon alpha 51 ChronVac C R 51 anticancer therapeutics 51 Tumor Necrosis Factor 51 Fenretinide 51 reversible inhibitor 51 intravesical instillation 51 histone deacetylase 51 Prodrug 51 CIMZIA ™ 51 intranasal delivery 51 Epidermal Growth Factor Receptor 51 PI3K/mTOR 51 Phase 2a Trial 51 peptide conjugated 51 depsipeptide 51 Hormone Refractory Prostate Cancer 51 pertuzumab 51 murine model 50 HDL Selective Delipidation 50 Hedgehog pathway inhibitor 50 mGluR2 NAM 50 Prolongs Survival 50 Inflammatory Diseases 50 cytotoxics 50 administered subcutaneously 50 SuperAntibody 50 Proteasome 50 HuMax 50 chimeric monoclonal antibody 50 Renal Cell Cancer 50 Tesmilifene 50 Replacement Therapy 50 direct thrombin inhibitors 50 5 HT2C receptor 50 Dalbavancin 50 IKK epsilon 50 PEG IFN 50 Photodynamic therapy 50 Monoclonal antibody 50 Hydroxyurea 50 Morpholino 50 TLR antagonists 50 selective inhibition 50 Hsp# Inhibitor 50 Successfully Completes Phase 50 monoclonal antibody MAb 50 MET VEGFR2 50 cyclin dependent kinase inhibitor 50 PEGylated interferon 50 Late Breaker 50 Phase III randomized controlled 50 EZN 50 histone deacetylase inhibitor 50 Bioral ® 50 Kinase Inhibitors 50 uricase 50 ALN TTR 50 Therapeutic Vaccine 50 antisense inhibitors 49 Cardiotoxicity 49 aurora kinase 49 Entry Inhibitor 49 GHRH 49 Talotrexin 49 thyroid hormone receptor 49 Mutation Analysis 49 liposome injection 49 Anti Phospholipid Therapy 49 immunomodulatory agents 49 Valopicitabine 49 Gleevec resistant 49 novel immunotherapeutic 49 preclinical efficacy 49 TRAIL receptors 49 p# biomarker 49 Glatiramer acetate 49 CCR5 antagonist 49 Abstract P# [002] 49 Immunomodulatory 49 VitiGam 49 delipidation 49 Arcelis ™ 49 Aplidin R 49 epoetin alpha 49 Jon Kamp 49 ZFP Therapeutic TM 49 Pegylated Interferon 49 combinability 49 BiTE 49 IFN beta 49 Nanobodies 49 PegIFN RBV 49 ESBA# 49 HCV polymerase 49 Denufosol 49 peptidic 49 Technosphere ® 49 Convection Enhanced Delivery 49 Carfilzomib 49 mda 7 49 MEK inhibitor 49 PSMA ADC 49 multikinase inhibitor 49 antagomirs 49 HCV polymerase inhibitor 49 NEUGENE 49 Hepatocellular Carcinoma 49 Solid Tumors 49 Protease Inhibitors 49 Polymerase Inhibitor 49 DiLA2 49 RNAi Therapeutics 49 ritonavir boosted 49 Katie Fehrenbacher Apr. 49 Chemokine Receptor 49 Antifungal 49 Zenvia Phase III 49 Bendavia 49 Ichor Medical Systems 49 recurrent glioma 49 humanized monoclonal antibodies 49 Diabetic Foot Ulcer 49 intravenous recombinant 49 Glycosylation 49 TLR antagonist 49 peptidomimetic 49 IFN alpha 49 PI3K inhibitor 49 Btk Inhibitor PCI 49 DermaVir Patch 48 Sym# 48 Anti angiogenic 48 Cyclosert TM 48 CCR5 mAb 48 Manan Kakkar 48 oral renin inhibitor 48 Kahalalide F 48 ZFP TF 48 Demonstrates Efficacy 48 Pramlintide 48 benzimidazole 48 DAS# Fludase ® 48 Interferon Beta 48 Protein Kinase C 48 proteasome inhibitors 48 immunoregulation 48 anti angiogenic agent 48 MAb 48 interferon lozenges 48 Immunosuppression 48 G Protein Coupled 48 Therapeutic Approaches 48 Radezolid 48 ZYBRESTAT TM 48 PARI Pharma GmbH 48 CLL SLL 48 Preclinical Evaluation 48 GRNCM1 48 XYOTAX TM paclitaxel poliglumex 48 Rigel R# 48 BMS # 48 radiotherapeutic 48 cleavable linker 48 indibulin 48 CITIGROUP RAISED ITS 48 cynomolgus monkeys 48 Sipuleucel T 48 TMC Fri 48 By Annemarie Mannion 48 Adult Stem Cell Therapy 48 Signaling Pathway 48 Potent Antiviral Activity 48 Transdermal Delivery 48 Telbivudine 48 Oritavancin 48 JVRS 48 vinblastine 48 trastuzumab Herceptin ® 48 BiTE Antibody 48 Pertuzumab 48 ASCO abstract 48 REMINYL ® 48 ALN HTT 48 cytochrome P 48 non nucleoside HCV 48 eFlow Technology 48 Tumor Response 48 SGLT 48 JAK Inhibitor 48 ENMD # 48 LT NS# 48 Monoclonal Antibody 48 TMC Sat 48 VNP#M 48 Hydra Biosciences 48 Antiangiogenic 48 HQK 48 Thiovir 48 novel prodrug 48 Transcranial Magnetic Stimulation TMS 48 MicroDose 48 vivo potency 48 vivo preclinical 48 Autoimmune Diseases 48 Novasome R 48 Cytoxan ® 48 Etravirine 48 immune modulation 48 compound AEZS 48 Progenitor Cells 48 Nick Breckon Aug 48 Geron telomerase inhibitor 48 sipuleucel T 48 Poster Discussion 48 Novel Therapies 48 Periowave Dental Technologies 47 mGluR5 antagonist 47 stem cell mobilizer 47 AVI NEUGENE 47 Poster Presentation 47 SR# [004] 47 aerosol formulation 47 Small Molecules 47 KRN# 47 Anticalins 47 Biological Therapy 47 HCV Genotype 47 HER2 ErbB2 47 JAK2 inhibitors 47 Protease Inhibitor 47 isotype 47 Hepatic Encephalopathy 47 Onconase 47 BAL# [002] 47 Introgen ADVEXIN 47 recurrent acute pancreatitis 47 ARRY # 47 preclinically 47 nucleotide analogs 47 hepatoma 47 NRTI resistance 47 Receptor Antagonist 47 Christopher Weddle 47 potently inhibit 47 SCI FI Tue 47 intratumoral injection 47 radionuclide therapy 47 antisense oligonucleotide 47 anti CD# antibodies 47 MAX Sat 47 NEUGENE antisense 47 Clinical Outcome 47 Bruton tyrosine kinase Btk 47 Ocular Diseases 47 anti CD3 47 NSCLC tumors 47 Monoclonal Antibodies 47 radiolabeled 47 nasally delivered 47 mouse xenograft models 47 AIR# [001] 47 By hb Jun 47 Gopalan T 47 virosome 47 Btk inhibitor 47 Contrast Agents 47 Cathepsin S 47 immunotherapeutic vaccine 47 Selective Cardiac Myosin Activator 47 cationic lipid 47 Ataluren 47 mediated inhibition 47 POAG 47 LEAPS TM 47 PEG SN# 47 R roscovitine 47 latanoprost 47 Nataline Sarkisyan died 47 Assay Kits 47 WAM ES 47 Biomarker Study 47 HDL Mimetic Peptide 47 RNAi Therapeutic 47 Phase Ib clinical 47 FTB MIA 47 Neuroprotection 47 1α 47 solithromycin 47 SHO Sat 47 Histone Deacetylase 47 HYLENEX recombinant 47 SCI FI Thu 47 Small Molecule 47 intradermal injections 46 Dendritic Cells 46 Mary Lahammer Published 46 Tumor Targeting 46 Gamepros #/#/# #:#:# PM 46 Antisense 46 Systemic Delivery 46 Nilotinib 46 virus AAV 46 Allogeneic 46 Pharmacodynamics 46 Modulates 46 GAMER DUDE AT 46 atazanavir Reyataz 46 IFN α 46 Targeted Therapy 46 By Mick Swasko 46 MenACWY 46 Owen Courrèges #/#/# 46 Bevasiranib 46 plasmid DNA vaccine 46 By hb Apr 46 Gastrointestinal Cancers Symposium 46 BIO InvestorForum 46 immunostimulatory 46 SMIP 46 Beta catenin pathway 46 Elvitegravir 46 By hb Oct 46 Deforolimus 46 TLR8 agonist 46 EXJADE 46 delafloxacin 46 antisense oligonucleotides 46 azacytidine 46 MAX Fri 46 Dasatinib 46 inhaled AAT 46 GRNVAC1 46 ON #.Na 46 maturation inhibitor 46 TMC Thu 46 Cyclosert 46 AEMD 46 Thrombin 46 Vitro Activity 46 HTRF 46 RAV# 46 Drug Formulation 46 MidnightTrader.com March 46 Interferon Alpha 46 Bay Packers PKRnews 46 Brian Gaar 46 Chemokine 46 ENC Sun 46 LHRH 46 Optical Coherence Tomography 46 HOLD FOR RELEASE UNTIL 46 AMC Thu 46 FROM MIDNIGHT 46 tkRNAi 46 By hb Nov 46 AMC Fri 46 Neoplasms 46 By hb Sep 46 RULED AT 46 NK1 46 Nasdaq EMIS 46 By hb Dec 46 stable nucleic acid 46 flavopiridol 46 orally dosed 46 telomerase activator 46 SCI FI Sat 46 Transmembrane 46 siRNA therapeutic 46 TBS Sat 46 Novel Therapeutic 46 Modrenal 46 Associated Diarrhea 46 cMET 46 Cytotoxic T 46 AMC Sat 46 GLP toxicology studies 46 IRHs 46 recombinant adeno associated 46 TPV r 46 PG HBO2 46 Novavax VLP vaccine 46 MYRX 46 Hsp# inhibitor STA 46 nucleotide analogues 46 hydroxamic acid 46 interstitial brachytherapy 46 COCAINE SURPLUS AT 46 MediVas 46 By hb Jul 46 Stacey Higginbotham Mar. 46 Taligen Therapeutics 45 Therapeutic Targets 45 lipid nanoparticle 45 By Brenna Hillier 45 bispecific antibody 45 AMC Wed 45 MAX Mon 45 CCR1 45 ACC2 45 mp Aug 45 R HBO2 45 hb Jan 45 annexin 45 pharmacodynamic properties 45 acyltransferase 45 PSMA antibody 45 Stapled Peptide 45 HBO Tue 45 CRLX# 45 XTEN 45 SCI FI Sun 45 Multichannel News #/#/# #:#:# [002] 45 peginterferon alpha 45 By mp Sep 45 fusion inhibitor 45 cytotoxicity assays 45 TNT Sat 45 IFN alpha XL 45 Alkaline Phosphatase 45 TAKSTA 45 By hb Mar 45 CET/# 45 monoclonal antibody mAb 45 Immune Therapy 45 Dicer substrate 45 PARP Inhibitor 45 PNT# 45 BMS# 45 AM CC 45 Spectrum Disorders 45 gp# protein [002] 45 Potent Inhibitor 45 Inflammatory Disease 45 By Addie Broyles 45 Eligen R B# 45 BKT HOU 45 By Maureen OConnor 45 Universal Flu Vaccine 45 Chris Faylor Dec 45 annexin V 45 PM CC 45 HTS assay 45 nonpsychiatric 45 BigJolly #/#/# #:# 45 SMT C# 45 Brittany Ballenstedt #/#/# 45 By Megan Gildow 45 Schizophrenia Treatment 45 #:#-# [031] 45 radiolabeled monoclonal antibody 45 Rick McCrabb Staff Writer 45 antisense compounds 45 Inflammatory Arthritis 45 Interferon Gamma 45 Clinical Trial Data 45 thromboembolism 45 telomerase inhibitor 45 Epothilone 45 Myeloperoxidase 45 IgG1 antibody 45 PG STARZ 45 Angiogenesis 45 Micromet BiTE 45 Exemestane 45 NEUGENE R 45 Nicotinic 45 N CC TVPG 45 levodopa induced dyskinesia 45 Mutational 45 AMC Tue 45 Derek Wallbank Published 45 WPTA Channel 45 SynCon TM DNA 45 Controlled Release 45 anti CD3 antibody 45 GPCR targets 45 siRNAs targeting 45 microtubule targeting 45 By Ujala Sehgal 45 Podium Presentation 45 David Weigel #/#/# [001] 45 NOD SCID mice 45 BY Cliff Kuang 45 RNase L 45 Therapeutic Agents 45 Estrogen Receptor 45 mp Mar 45 bigjolly #/#/# #:# 45 genitourinary cancers 45 Sharon Schmickle Published 45 SCI FI Wed 45 sd rxRNA compounds 45 HSP# inhibitors 45 ART# 45 siRNA therapeutics 45 HOLD FOR RELEASE 45 TMC Tue 45 morpholino 45 Chris Faylor Jun 44 leftofwhat 44 SCI FI Fri 44 Warrant Arrest 44 LIFE Tue 44 vorinostat 44 lipid nanoparticles 44 Pharmacologic 44 A3 adenosine receptor 44 Chris Faylor Oct 44 potent suppressor 44 By hb Feb 44 Enhanze Technology 44 adducts 44 Refractory Angina 44 Radio WADO 44 peptide antigens 44 marco# 44 Tablet Formulation 44 SUND Wed 44 OR PUBLISHED BEFORE 44 By Wily Ferret 44 By Justin Rohrlich 44 mp Jan 44 seahawks# 44 NASDAQ NPSP 44 By Lawerence Synett 44 CYBX 44 RICHARD L. ELDREDGE 44 kamrom 44 ACTCellerate 44 Tumor Progression 44 neuroblastoma tumors 44 Hematopoietic Stem Cells 44 AZT 3TC 44 ASCO GU 44 Lisa Halverstadt Apr. 44 Nell Sloane #/#/# 44 Inc. Nasdaq TELK 44 Fibroblast 44 Mucosal 44 EGFR inhibition 44 CC TVPG 44 LIFE Sat 44 RICE BRAN Rs 44 5 HT4 receptor 44 Chemotherapeutic Agents 44 By Mark Serrels 44 By Alan Trubow 44 Melanie Pinola 44 Pharmacological 44 christopher howard 44 BBL SEA 44 HIF PH inhibitors 44 WISE Channel 44 TBS Thu 44 NN# [001] 44 LUTS 44 HBO Thu 44 By hb Aug 44 Cystic Fibrosis Transmembrane conductance 44 transcranial Doppler ultrasound 44 WANE Channel 44 Ed Brayton #/#/# [002] 44 By Toby McCasker 44 Bruton tyrosine kinase 44 pmET 44 Matt Bramanti #/#/# 44 BY VENOMUS AT 44 David Brauer Published 44 Pharmacodynamic 44 Protease 44 Hannah Poturalski Staff Writer 44 Michael Hoinski 44 nanoviricides 44 http:/investor.kelloggs.com 44 Btk Inhibitor 44 PT/# 44 enzyme inhibitors 44 Somatostatin 44 Idolator Staff 44 lifts Buttermilk Wed 44 UsiRNAs 44 Cannabinoid 44 Kareem Elgazzar Staff Writer 44 Breast Brachytherapy 44 Chris Faylor Nov 44 pramlintide metreleptin combination 44 www.panacos.com 44 Lung Tumors 44 Ed Brayton #/#/# [004] 44 chemokine receptor 44 SPIKE Sun 44 onlineathens.com Story updated 44 mp Oct 44 subunit vaccines 44 Annie Lowrey #/#/# [001] 44 Anne Cassidy campaignlive.co.uk 44 Phase IIA 44 recombinant protein 44 maturation inhibitors 44 KSL Newsradio #.# FM/# 44 Dradeeus 44 Anticancer Agents 44 BY MALDRON AT 44 aurora kinase inhibitor 44 Bill Tiller Rawhide 44 Clusterin 44 SNALP formulations 44 Thrombin Processing Device 44 Allosteric 44 pm WSLI 44 Newsbreak #/#/# 44 pharmacokinetic characteristics 43 tkRNAi technology 43 Targeted Therapeutics 43 Targeted Therapies 43 By Jarett Wieselman 43 Analogs 43 RNA Interference 43 RickG #/#/# #:# 43 Preclinical Study 43 http:/ca.com/invest/ 43 imatinib mesylate Gleevec 43 #:#-# [033] 43 BY WITZBOLD AT 43 Novel Therapeutics 43 BioReference Laboratories presentation 43 ENC Fri 43 deCODE chemistry 43 David Weigel #/#/# [002] 43 Renal Insufficiency 43 By Adam Dachis 43 Lucentis ranibizumab Genentech 43 prophylactic vaccine 43 metabolite identification 43 Modified Seldinger Technique 43 Inc. NASDAQ SYNO 43 Cytotoxicity 43 Radio WPHT 43 TURKEY PRESS SCAN 43 BY SABRE JUSTICE AT 43 TLR8 43 allergic airway inflammation 43 phosphatidylserine PS targeting 43 telomerase activators 43 mp Nov 43 pm ET/# 43 PM EST/# 43 BY HUGINN AT 43 Monoclonal 43 Highly Potent 43 BY ENIGMANEMESIS AT 43 Ultrafast Insulin 43 ThomasJH# 43 Tumor Suppressor 43 Oligonucleotide 43 BY STRIDER MT2K AT 43 Placebo Controlled Trial 43 indigo# 43 am CT/# 43 By SUSAN MCMILLAN 43 Microsoft Deployment Toolkit 43 Thymosin beta 4 43 Biologic Therapy 43 DNA Methylation 43 Anticalin ® 43 Ed Masley Apr. 43 nanoparticle formulation 43 WBEN Newsroom 43 By Joe Felicelli 43 BY KIRBYTHESLAYER AT 43 Porkeater 43 Jim Matheson edmontonjournal.comMarch 43 Adjuvant Breast Cancer 43 entitled Synergistic 43 SUND Fri 43 midnight Tues. Thurs 43 Chris Steller #/#/# [002] 43 Jitterbug Dancing Saturdays 43 Cancer Vaccines 43 Lucanix 43 Ed Huyck Published 43 ISF# 43 affinity ligands 43 AtuRNAi 43 ROGER SIMON #/#/# 43 TMC Mon 43 Beta Amyloid 43 Solorel TM 43 PhG alpha 1 43 protein tyrosine phosphatase 43 Pamela Espeland Published 43 novel vascular disrupting 43 BY MOSSBERG AT 43 p.m. ET 43 Assay Kit 43 LINE UNDER BASKETBALL 43 By Mark Lisheron 43 Ed Brayton #/#/# [001] 43 • jmicale@gannett.com • 43 BY KURAUDO AT 43 Jim Kouri #/#/# #:#:# [002] 43 BY DIGITALHERO AT 43 DIRK DA GOD 43 sd rxRNA 43 Transgenic Mice 43 #:#-# [035] 43 ASH Annual Meeting 43 Jonny Lyman 43 Listeria vaccine 43 EXPORT FAS 43 Joe Mandese Today 43 viral kinetics 43 TO NOON 43 mp Feb 43 BY HELIOPHAGE AT 43 Aptamer 43 AARON KRAUSE Reflector 43 Paul Schmelzer #/#/# 43 Avi Zenilman #:# 43 txthinker 43 Nicole Klauss 43 adult mesenchymal stem 43 am PT/# 43 Signaling Pathways 43 iron dextran 43 BY THEIRISHNINJA AT 43 ritonavir boosting 43 QT Prolongation 43 therapeutically relevant 43 Factor 5A 43 trodusquemine 43 ET/# 43 Anticancer Drug 43 Mimetics 43 darunavir Prezista 43 BY CHICKENOFTHESEA AT 43 retroviral vectors 43 By Kyle VanHemert 43 WFFT Channel 43 S#P# 43 NMES 43 SABCS 43 LIFE Wed 43 AdnaTest 43 Intrinsic Bioprobes 43 tumor antigen 43 By mp Jun 43 Protein Kinase 43 Bill Goodykoontz Apr. 43 ForTheLoveOfEllipsis 43 POSTED #:# 43 Reverse Transcriptase 43 By mp Apr 42 BY PAPABEAR# AT 42 Belky Says 42 cyclophilin inhibitor 42 Progenitor Cell 42 subclinical hypothyroidism 42 microparticle 42 dmhack 42 Mark Fightmaster mfightmaster@sir-inc.com #/#/#xinhuanet 42 PDT 42 BY TUFFY AT 42 Silvio Pietroluongo NY 42 BY GREEN CLAD 42 c# #/#/# URL http:/www.newswire.ca/releasSok Sok 42 hERG 42 mata ruach 42 Genotypes 42 Histone 42 Cancer Stem Cells 42 mary# 42 EDT/# 42 antitumoral 42 quadrivalent human papillomavirus 42 gamma secretase inhibitors 42 vitro cytotoxicity 42 ENC Tue 42 Invent Scandal 42 BY GAMEMASTER AT 42 Jocelynn Drake jdrake@sir-inc.com #/#/# [002] 42 By Kirk Ladendorf 42 BY CEILINGFANBOY AT 42 TCM Wed 42 • jwhong@gannett.com • 42 murine monoclonal antibody 42 Annie Lowrey #/#/# [002] 42 MONSTER SPECTACULAR Saturday 42 # #-# [004] 42 Staff marketingmagazine.co.uk 42 Jeff Bercovici #/#/# 42 thaneb 42 Exenatide Byetta 42 IgM antibody 42 Conchobhar 42 BY SHINDOKIE AT 42 Clinical Evaluation 42 By Rosa Golijan 42 Tim Colwill Mon 42 SIMON SHUSTER Posted 42 affective psychoses 42 Myeloproliferative 42 HepG2 cells 42 Nick Breckon Jul 42 BY MOONSHADOW# AT 42 By Miguel Liscano 42 • adnorthington@gannett.com • 42 TCM Fri 42 Chris Faylor Sep 42 Extracellular Matrix 42 Joseph Hargett jhargett@sir-inc.com #/#/# [001] 42 Scientific Poster Session 42 John Tomasic #/#/# [001] 42 TCM Mon 42 tumor lysate 42 FAM Sat 42 CCR2 42 Macrophage 42 Désiré Athow 42 Stakeholder Opinions 42 Open Tue. Sun 42 Tumor Angiogenesis 42 Epitope 42 ScienceBuff 42 AACR NCI EORTC 42 foghornleghorn 42 TCM Sat 42 nonviral 42 NASDAQ ARYX biopharmaceutical 42 PD 42 By Sara Daehn 42 Vivecon 42 Immunogenicity 42 Coty Dolores Miranda 42 KNSY 42 curiousindependent 42 Dr. Trupti Shirole 42 The Cat 42 Mariel Concepcion NY 42 Ed Brayton #/#/# [003] 42 TCM Thu 42 7PM CT 42 pDNA vaccines 42 BY TEDSEZ AT 42 NABTT 42 Mesenchymal Stem Cells 42 siRNA duplexes 42 Central Time/# 42 Regimens 42 JOE LOGAN #/#/# #:#:# 42 Leah Nylen 42 murine models 42 DermaVir